Beijing Tongrentang Group ratchets up its overseas play through branches, M&A, R&D and training courses

Beijing Tongrentang Group Co Ltd, the world's largest producer of traditional Chinese medicine, plans to increase investment outside China and open at least 200 overseas branches in the next five years.

"We will establish localized factories in mature overseas markets, open TCM clinics and healthcare centers," said Ding Yongling, vice-president of Tongrentang.